ISSCR News
Immature Brain-Supporting Cells Switch Fate to Restore Blood Flow After Stroke
Stroke is a leading cause of death and disability, affecting 1 in 4 people during their lifetime. Stroke happens when blood vessels in the brain get clogged or damaged, impairing blood flow and oxygen supply to the brain, which leads to death of neurons and other brain cells. Although brain damage can be limited by interventions to restore blood flow, most stroke survivors experience some lifelong impairments of e.g. speech, movement, or cognitive function.
Despite the existence of immature stem cells in the brain, their role in repair is uncertain and the brain’s ability to recover from stroke remains limited. Takakuni Maki, Ken Yasuda, Kazuto Tsukita, and colleagues from Kyoto University, Japan, have now demonstrated that oligodendrocyte progenitor cells (OPCs)—a well-known immature glial cell type in the brain—can promote new blood vessel formation after stroke under hypoxic conditions. The research was published today in Stem Cell Reports.
Registration and Abstract Submission Are Open For ISSCR 2026 in Montréal 8-11 July
The International Society for Stem Cell Research (ISSCR) has opened registration and abstract submission for the ISSCR 2026 Annual Meeting, taking place 8-11 July 2026 in Montréal, Canada. The Global Stem Cell Event will bring together academic and industry leaders driving progress in stem cell science and regenerative medicine.
STEMCELL Technologies will co-sponsor the hallmark event, continuing a valued collaboration that underscores the importance of partnership between science and industry in advancing the field.
The ISSCR Launches Roadmap for Developing Pluripotent Stem Cell-Derived Therapies
New Guidance Aims to Enhance the Translation of Cell Therapies
The International Society for Stem Cell Research (ISSCR) is proud to announce the release of Best Practices for the Development of Pluripotent Stem Cell-Derived Cellular Therapies, a comprehensive new resource designed to accelerate the translation of human pluripotent stem cell (PSC)-derived therapies into clinical trials and commercial use.
Developed by leading international experts in cell therapy, this groundbreaking document outlines the key principles and decision points required to develop safe, effective, and regulatory compliant PSC-derived products. Organized into seven sections, the guidance offers jurisdictionally neutral information on topics ranging from PSC line selection and raw material use to regulatory considerations, preclinical studies, and clinical trials.
ISSCR Remembers Sir John Gurdon
The International Society for Stem Cell Research (ISSCR) joins the global scientific community in mourning the loss of Nobel Laureate Professor Sir John Gurdon, whose visionary discoveries forever changed our understanding of biology and inspired generations of scientists around the world.
Professor Gurdon’s pioneering nuclear transfer experiments in frogs answered one of the most fundamental questions in biology, whether specialized cells retain the full genetic blueprint of life. His landmark demonstration that the nucleus of a mature cell could direct the development of an entire organism laid the foundation for fundamental advances in stem cell science.
Stem Cell Reports Welcomes New Members to Its Editorial Board
Expanding the depth and breadth of scientific expertise that defines Stem Cell Reports, the official journal of the International Society for Stem Cell Research, 13 distinguished researchers have joined the Editorial Board. Their appointment broadens representation across the diverse and international landscape of stem cell science and reinforces the Board’s commitment to championing the journal, raising its global visibility, and ensuring rigorous, high-quality peer review.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .